Home/BIT Pharma/Prof. Dr. Jörg Breitenbach

PD

Prof. Dr. Jörg Breitenbach

Chief Executive Officer

Therapeutic Areas

Central Nervous System

BIT Pharma Pipeline

Drug	Indication	Phase
NicaPlant®	Undisclosed CNS condition(s) (High unmet medical need, life-threatening)	Pre-clinical

Leadership Team at BIT Pharma

Dr. Tiziana Adage

Chief Scientific Officer

Dr. Doris Maier

Chief Financial Officer

Prof. Dr. Peter Vajkoczy

Clinical Advisor

Dr. Peter Hölig

Technology Development Expert

View full BIT Pharma profile